Month: April 2020
Excerpt from the article: “DURHAM — Front-line health-care workers dealing with the COVID-19 pandemic are getting a helping hand from Ontario Power Generation and Ontario Tech University in Oshawa. OPG is using 3D printing technology to produce plastic face shields and the company has partnered with Ontario Tech University to fast-track the production of this…
Read More
Excerpt from the article: “RICHMOND, Va. (WRIC) — VCU Health is in the middle of conducting clinical trials for an experimental drug that could possibly treat COVID-19. Dr. Arun Sanyal, the doctor leading the trials, told 8News Tuesday that results are encouraging and it’s about improving how a patient feels, functions and survives. Remdesivir, a…
Read More
Excerpt from the Article: “Hemarina, a French biotech company, could come to the help of doctors fighting the coronavirus. The company has developed a molecule derived from marine worms, which could help people seriously affected by the COVID-19, who do not have access to respirators. The molecule called M101, binds 40 times more oxygen than…
Read More
Excerpt from the article: “PORTLAND, Ore. — Providence researchers in Portland submitted a request to the Food and Drug Administration for the first clinical trial of a viral COVID-19 vaccine. The Earl A. Chiles Research Institute (EACRI) at Providence’s Robert W. Franz Cancer Center is using its knowledge of cancer vaccine immunotherapy to develop a…
Read More
Excerpt from the article: “A team of blood transfusion experts from across Canada is planning the world’s largest clinical trial of a potential treatment for COVID-19. The study, which will involve 1,000 patients from across the country, will include at least 40 Canadian hospitals, and is being overseen by doctors from the University of Montreal,…
Read More
Excerpt from the article: “The Food and Drug Administration is expected to approve the first of a whole new type of weapon to be tested in the international struggle against COVID-19 as the disease continues to sweep across the globe. New Jersey-based therapeutics company Celularity announced that its cancer treatment, CYNK-001, is awaiting “investigational new…
Read More
Meaghan Powers, lead consultant, Halloran Consulting Group penned an excellent article on integrating Quality Management with RBM Meaghan tackles a number topics in the 3 Key Steps To Successful Execution. First, a risk assessment must be conducted both pre-study and ongoing during the trial. Second, a well-articulated study protocol should be developed based on factors…
Read More
Excerpt from the article: “Genomics health technology startup Color is doing its part to address the global COVID-19 pandemic, and has detailed the steps it’s taking to support expansion of testing efforts in a new blog post and letter from CEO Othman Laraki on Tuesday. The efforts include development of a high-throughput lab that can…
Read More
Excerpt from the article: “A test that can determine if a patient had been infected and recovered from COVID-19 is being developed at Mayo Clinic Laboratories. The test will detect the presence of antibodies specific to SARS-CoV-2, the virus that causes COVID-19. Antibodies are produced by a person’s immune system, and are critical for control…
Read More
Excerpt from the article: “It’s highly unlikely that the current coronavirus crisis will be neatly and fully “solved” by any one endeavor or solution, which makes new studies like one involving startup WHOOP’s wrist-worn fitness and health tracking wearable all the more important. The study, conducted by the Central Queensland University Australia (CQUniversity), in partnership…
Read More- « Previous
- 1
- 2
- 3
- Next »